CAS 417719-51-8

DescyclopropylLenvatinib

CAS : 417719-51-8

Formule : C₁₈H₁₅ClN₄O₄

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 386.7891

Ref: IN-DA01E4GN

4-(3-Chloro-4-ureidophenoxy)-7-methoxyquinoline-6-carboxamide

CAS : 417719-51-8

4-(3-Chloro-4-ureidophenoxy)-7-methoxyquinoline-6-carboxamide

Degré de pureté : 98%

Masse moléculaire : 386.8g/mol

Ref: 54-OR1062047

Lenvatinib Impurity 9

CAS : 417719-51-8

Formule : C₁₈H₁₅ClN₄O₄

Masse moléculaire : 386.79

Ref: 4Z-L-124013

Descyclopropyl Lenvatinib

CAS : 417719-51-8

Formule : C₁₈H₁₅ClN₄O₄

Masse moléculaire : 386.79

Ref: ST-EA-CP-L14009

Descyclopropyl Lenvatinib

Produit contrôlé

CAS : 417719-51-8

Applications Descyclopropyl Lenvatinib is a metabolite of Lenvatinib (L329400) which is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors.
References Matsui, J., et al.: Clin. Cancer Res., 14, 5459 (2008); Gild, M., et al.: Nature Rev. Endocrinol., 7, 617 (2011)

Formule : C₁₈H₁₅ClN₄O₄

Couleur et forme : Red Brown

Masse moléculaire : 386.79

Ref: TR-D288150

Descyclopropyl lenvatinib

CAS : 417719-51-8

Descyclopropyl lenvatinib is a synthetic drug candidate that is being developed for the treatment of cancer. It is a metabolite of lenvatinib and has shown to have similar pharmacological activity, including inhibition of protein synthesis. Descyclopropyl lenvatinib also has been shown to inhibit the metabolism of other drugs, such as irinotecan, which may be due to its ability to inhibit cytochrome P450 enzymes.

Formule : C₁₈H₁₅ClN₄O₄

Degré de pureté : Min. 95%

Masse moléculaire : 386.80 g/mol

Ref: 3D-SRA71951